Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Akamai slides as investors refocus on 2026 margin and capex pressure despite AI-related momentum

None

Akamai Technologies (AKAM) is down 3.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to investor sensitivity around Akamai’s 2026 profitability trajectory, with elevated capital spending expectations weighing on near-term margin sentiment. Even with positive AI/cloud announcements, some of the most meaningful revenue impact is back-end loaded, which can lead to “sell the news” price action.

Details:

  • Akamai’s latest outlook embedded higher 2026 investment levels (including data center and GPU-related buildout), which can pressure operating margins even if revenue trends hold up.
  • The company has discussed a large multi-year cloud services commitment centered on AI inference, but it has also indicated revenue recognition timing that begins later, limiting near-term earnings lift.
  • In its most recent full-year outlook framework, Akamai’s 2026 adjusted EPS range was viewed as conservative versus prior expectations, reinforcing concerns that 2026 may be an “investment year.”
  • This could also be simple profit-taking after recent volatility around guidance and AI infrastructure positioning.
  • Sources:

    Akamai, Akamai, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $AKAM Insider Trading Activity

    AKAM Insider Trades

    $AKAM insiders have traded $AKAM stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.

    Here’s a breakdown of recent trading of $AKAM stock by insiders over the last 6 months:

    • ADAM KARON (COO & GM Edge Technology Group) has made 0 purchases and 3 sales selling 25,048 shares for an estimated $2,574,275.
    • MANI SUNDARAM (EVP and GM Security) has made 0 purchases and 6 sales selling 23,988 shares for an estimated $2,301,007.
    • PAUL C JOSEPH (EVP - Global Sales) has made 0 purchases and 6 sales selling 20,000 shares for an estimated $1,803,831.
    • EDWARD J MCGOWAN (Chief Financial Officer) has made 0 purchases and 2 sales selling 13,745 shares for an estimated $1,390,924.
    • ROBERT BLUMOFE (Chief Technology Officer) has made 0 purchases and 4 sales selling 13,500 shares for an estimated $1,281,550.
    • AARON AHOLA (EVP & General Counsel) has made 0 purchases and 2 sales selling 12,000 shares for an estimated $1,218,166.
    • JON MILLER sold 11,000 shares for an estimated $1,129,370
    • LAURA HOWELL (SVP, Chief Accounting Officer) sold 11,273 shares for an estimated $1,128,822
    • MADHU RANGANATHAN sold 3,131 shares for an estimated $319,362

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

    $AKAM Hedge Fund Activity

    We have seen 333 institutional investors add shares of $AKAM stock to their portfolio, and 411 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

    $AKAM Government Contracts

    We have seen $505,538 of award payments to $AKAM over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

    $AKAM Congressional Stock Trading

    Members of Congress have traded $AKAM stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

    Here’s a breakdown of recent trading of $AKAM stock by members of Congress over the last 6 months:

    • REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

    $AKAM Analyst Ratings

    Wall Street analysts have issued reports on $AKAM in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Scotiabank issued a "Sector Outperform" rating on 01/09/2026
    • Keybanc issued a "Overweight" rating on 12/15/2025
    • Oppenheimer issued a "Outperform" rating on 11/17/2025
    • DA Davidson issued a "Buy" rating on 10/16/2025

    To track analyst ratings and price targets for $AKAM, check out Quiver Quantitative's $AKAM forecast page.

    $AKAM Price Targets

    Multiple analysts have issued price targets for $AKAM recently. We have seen 13 analysts offer price targets for $AKAM in the last 6 months, with a median target of $110.0.

    Here are some recent targets:

    • James Fish from Piper Sandler set a target price of $97.0 on 02/23/2026
    • Jackson Ader from Keybanc set a target price of $120.0 on 02/20/2026
    • Amit Daryanani from Evercore ISI Group set a target price of $115.0 on 02/20/2026
    • Roger Boyd from UBS set a target price of $110.0 on 02/20/2026
    • William Power from Baird set a target price of $110.0 on 02/20/2026
    • Michael Elias from TD Cowen set a target price of $100.0 on 02/20/2026
    • Rishi Jaluria from RBC Capital set a target price of $100.0 on 02/20/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles